High BPA levels linked to increased prostate cancer risk in older men

A study in Nutrients found that higher urinary bisphenol A (BPA) levels are linked to increased prostate-specific antigen (PSA) and higher prostate cancer risk in senior American men. This suggests a need for heightened cancer screening, especially in high-risk groups.

Psychedelics’ dark side: New model reveals risks of false insights and beliefs

Researchers introduce the FIBUS model to explain how psychedelics can lead to false insights and beliefs, highlighting the need for careful clinical evaluation to optimize

August 5, 2024

Actimed plans trials to treat muscle wasting syndrome in cancer patients

Actimed plans to start two Phase IIb/III trials of its lead candidate in H1 2024. Credit: Shutterstock / Casa nayafana. UK-based Actimed Therapeutics is planning

July 13, 2023

Amid GLP-1 mania, health tech’s weight loss startups are trying to prove their services matter

(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) The rampant success of new prescription GLP-1

February 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.